Category Archives: Pharmaceutical Promotion

Therapeutic Goods Advertising Consultative Committee, First meeting today

This committee has replaced the now abolished Therapeutic Goods Advertising Code Council. Choice (Australian Consumers’ Association) was a member of previous Code Council (and Complaint Resolution Panel). No doubt the failure of the TGA to invite Choice to this new … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , | Leave a comment

Natural health products the largest selling OTC medicines in 2015–16

From Australia’s health 2018 (full publication; 4 June 2018 edition); see also: http://www.abc.net.au/news/2018-10-03/chart-of-the-day-natural-therapies-vitamins/10328514 These results reflect the large amount of money spent on marketing these products (Swisse $50 million per annum) and the failure of the regulator (the TGA) to act on … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , , , , , , , , | Leave a comment

APHC 2018 Contested Policy: Complementary Medicines and Advertising Reform

Chair: Ken Harvey Speakers: John Skerritt – Overview of MMD recommendations Alanna Rottler – Pre-approval of certain advertisements to cease Jon Wardle – Permitted indications to replace ARTG ‘free text’ Alanna Rottler – A new listing pathway (and an optional … Continue reading

Posted in Complementary medicine, Education, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

TGA advertising system concerns: response from TGA

For background see: http://www.medreach.com.au/?p=2778 From: SKERRITT, John <John.Skerritt@health.gov.au> Sent: Tuesday, 18 September 2018 21:13 To: ken.harvey@medreach.com.au Cc: MCLAY, Nicole <Nicole.McLay@health.gov.au>; FRANCIS, Jenny <Jenny.Francis@health.gov.au>; SKERRITT, John <John.Skerritt@health.gov.au> Subject: RE: Letter from ACCC – TGA advertising concerns [SEC=UNCLASSIFIED] Dear Dr Harvey Thank you … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , | Leave a comment

TGA advertising complaint system concerns: response from Minister Hunt and Ombudsman

Minister Hunt (or more likely the TGA) has now responded to my letter that expressed concerns about the new TGA advertising complaint system. The Minister confirms that the TGA’s advertising complaint system was designed to be non-transparent for low priority … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged | Leave a comment

Complaint to Commonwealth Ombudsman – TGA advertising complaint system

From 1 July 2018, the Therapeutic Goods Administration took over the complaint system for the advertising therapeutic goods to the public from the Complaint Resolution Panel (CRP). Many concerns about this TGA takeover were submitted in consultation submissions. They were … Continue reading

Posted in Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment

TGA new complaint system: compliance notices ineffective

Two outcomes (of 16) TGA complaints have now been received. AC-E7JS15BB/2018, submitted 3/8/18,  Brand Developers Australia Pty Ltd – Pain Erazor         https://www.youtube.com/watch?v=ye6s7qB-4Gc&feature=youtu.be “Pain Erazor” (ATG no: 276939) won a 2017 Choice “Shonky” award, was the subject of … Continue reading

Posted in Medical Devices, Pharmaceutical Promotion | Tagged , , , , , | 1 Comment

Launch of TGA Advertising Hub – Initial experience of submitting complaints

The TGA Advertising hub has noted: “We are experiencing intermittent IT issues that are impacting this form. If you experience an error lodging a complaint, please try again later. We are working to fix this issue as a matter of … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

TGA’s new complaint system fails the Ease-a-cold test; Outcomes of Advertising Complaints Investigations Specification 2018 enacted

Stimulated by an article in today’s “The Conversation” on Pharmacare Laboratories Ease-a-Cold (below), I decided to try the TGA’s new complaint system.As I mentioned in a comment on this article, this product has been the subject of a previous article … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , | Leave a comment

TGA Advertising Portal and Complaint System now live; Industry embrace permissible indications

See: https://www.tga.gov.au/advertising-hub and: https://ajp.com.au/news/tga-explains-new-advertising-landscape/ However, there are still concerns about the transparency of the new system and my colleagues and I are holding off submitting complaints until we know: The outcome of the TGA Consultation: Complaints handling – Advertising therapeutic goods to … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , | Leave a comment